OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2020
(3)
2021
(2)
2025
(1)
2022
(1)
2019
(1)
2018
(1)
2012
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Dissecting Tumor Size Underestimation in Pancreatic Cancer: A Comparative Analysis of Preoperative Treatments.
Not available
S-EPMC11976789
|
biostudies-literature
Cite
Utility of
18
F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging for Prediction of Metastasis to Sentinel and Nonsentinel Nodes in Patients with Clinically Node-Negative Breast Cancer.
Not available
S-EPMC7334280
|
biostudies-literature
Cite
The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model.
Not available
S-EPMC6173461
|
biostudies-literature
Cite
Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Not available
S-EPMC6882358
|
biostudies-literature
Cite
Comparison between AJCC 8th prognostic stage and UICC anatomical stage in patients with primary breast cancer: a single institutional retrospective study.
Not available
S-EPMC7567685
|
biostudies-literature
Cite
Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study.
Not available
S-EPMC9524130
|
biostudies-literature
Cite
Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.
Not available
S-EPMC7912898
|
biostudies-literature
Cite
Significance of mesothelin expression in preoperative endoscopic biopsy specimens for colorectal cancer prognosis.
Not available
S-EPMC7597413
|
biostudies-literature
Cite
Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer.
Not available
S-EPMC3389425
|
biostudies-literature
Cite
Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients.
Not available
S-EPMC8555316
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets